Ultrasound findings indicative of abnormal karyotype in fetuses with omphalocele
Study on the Efficacy of an Investigational Medication for Chronic Pain
Not Recruiting
100 years or below
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Omphalocele
Age:
100 years or below
Gender: All
Who can participate: Participants aged 18 to 65 years with a diagnosis of chronic pain for at least six months are eligible. Key exclusion criteria include recent surgery and current use of other investigational drugs.
Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. They will be required to attend regular clinic visits for assessments and provide feedback on pain levels and quality of life.
Updated on
19 Feb 2024.
Study ID: 1011002881 (0704-75)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
